Intensive blood pressure control does not benefit diabetes patients

According to new data from the Action to Cardiovascular Risk in Diabetes (ACCORD) trial has shown that there are no clear benefits to intensive blood pressure reduction amongst patients with diabetes . The research was published online in the New England Journal of Medicine .
The ACCORD study was a large-scale trial, including thousands of patients with type 2 diabetes . Many of those surveyed were assigned intensive blood pressure therapy . The likelihood of stroke decreased amongst participants who had intensive blood pressure control, but the chances of adverse events also increased.
Diabetes and blood pressure are closely linked, with incidence of diabetes greatly increasing blood pressure levels. The data from the ACCORD blood pressure trial indicates that although blood pressure control is an essential part of managing diabetes successfully, intensive therapy may be inappropriate.